We are live on ! Find out more
WRF

Waddell & Reed Financial Portfolio holdings

AUM $48.6B
1-Year Est. Return 84.78%
This Fund
S&P 500
This Quarter Est. Return
+7.28%
1 Year Est. Return
+84.78%
3 Year Est. Return
+132.84%
5 Year Est. Return
+281.73%
10 Year Est. Return
–
AUM
$45.1B
AUM Growth
+$94.6M
Cap. Flow
-$2.51B
Cap. Flow %
-5.57%
Top 10 Hldgs %
18.78%
Holding
580
New
61
Increased
167
Reduced
261
Closed
54

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$138M
2
JBHT icon
JB Hunt Transport Services
JBHT
+$110M
3
C icon
Citigroup
C
+$109M
4
TEL icon
TE Connectivity
TEL
+$90.5M
5
SWK icon
Stanley Black & Decker
SWK
+$88.8M

Top Sells

Rank Stock Value
1
PM icon
Philip Morris
PM
+$219M
2
KITE
Kite Pharma, Inc.
KITE
+$171M
3
CELG
Celgene Corp
CELG
+$161M
4
WFC icon
Wells Fargo
WFC
+$157M
5
CMCSA icon
Comcast
CMCSA
+$143M

Sector Composition

Rank Sector Weight
1 Technology 24.47%
2 Financials 14.41%
3 Consumer Discretionary 11.87%
4 Healthcare 11.47%
5 Industrials 10.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MS icon
51
Morgan Stanley
MS
$338B
$219M 0.48%
4,165,340
-424,616
-9% -$21.5M
BMRN icon
52
BioMarin Pharmaceuticals
BMRN
$12.2B
$218M 0.48%
2,447,876
+66,102
+3% +$5.75M
BAC icon
53
Bank of America
BAC
$441B
$218M 0.48%
7,384,239
+1,642,570
+29% +$45.3M
MET icon
54
MetLife
MET
$62.2B
$209M 0.46%
4,142,651
-35,892
-0.9% -$1.89M
FAST icon
55
Fastenal
FAST
$59.4B
$209M 0.46%
15,301,524
-816,116
-5% -$10.1M
ALXN
56
DELISTED
Alexion Pharmaceuticals
ALXN
$207M 0.46%
1,733,011
-363,676
-17% -$44.3M
LRCX icon
57
Lam Research
LRCX
$387B
$206M 0.46%
11,167,630
-4,346,740
-28% -$85.4M
SWK icon
58
Stanley Black & Decker
SWK
$15.7B
$193M 0.43%
1,135,570
+542,275
+91% +$88.8M
BX icon
59
Blackstone
BX
$110B
$184M 0.41%
5,753,996
+350,097
+6% +$11.4M
BFH icon
60
Bread Financial
BFH
$4.39B
$184M 0.41%
909,991
-482,531
-35% -$89.4M
SLB icon
61
SLB Ltd
SLB
$75.1B
$182M 0.4%
2,697,452
-204,439
-7% -$13.2M
MGA icon
62
Magna International
MGA
$18.8B
$182M 0.4%
3,207,186
+451,999
+16% +$24.8M
WBC
63
DELISTED
WABCO HOLDINGS INC.
WBC
$181M 0.4%
1,263,566
-53,086
-4% -$7.8M
LLY icon
64
Eli Lilly
LLY
$1.05T
$181M 0.4%
2,140,493
+805,567
+60% +$68.5M
PII icon
65
Polaris
PII
$4.06B
$178M 0.4%
1,436,944
-81,259
-5% -$9.64M
INTC icon
66
Intel
INTC
$510B
$174M 0.39%
3,768,659
+839,953
+29% +$36.7M
ZAYO
67
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$173M 0.38%
4,705,507
-14,000
-0.3% -$495K
CI icon
68
Cigna
CI
$74.5B
$173M 0.38%
850,011
-83,340
-9% -$16.6M
MRVL icon
69
Marvell Technology
MRVL
$194B
$170M 0.38%
7,909,000
+22,900
+0.3% +$467K
CSGP icon
70
CoStar Group
CSGP
$12.4B
$169M 0.37%
5,684,780
-316,870
-5% -$9.28M
COST icon
71
Costco
COST
$419B
$169M 0.37%
905,784
-136,509
-13% -$23.6M
ADI icon
72
Analog Devices
ADI
$190B
$168M 0.37%
1,884,519
-674,253
-26% -$59.7M
MNST icon
73
Monster Beverage
MNST
$88.7B
$168M 0.37%
5,298,554
-1,209,376
-19% -$36.2M
PXD
74
DELISTED
Pioneer Natural Resource Co.
PXD
$162M 0.36%
937,780
-11,360
-1% -$1.75M
TSCO icon
75
Tractor Supply
TSCO
$18B
$161M 0.36%
10,745,580
+168,245
+2% +$2.16M
1 2
3
4 5

Similar funds

SHP
Spruce House Partnership New York $3.49B AUM
SBSB
Sullivan, Bruyette, Speros & Blaney Mclean, Virginia $2.27B AUM 50.71% 1-Year Est. Return
PAG
Pinnacle Advisory Group Columbia, Maryland $2.17B AUM 39.21% 1-Year Est. Return
BUB
BBVA USA Bancshares Houston, Texas $2.1B AUM 62.57% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
PPCM
Pillar Pacific Capital Management Pacifica, California $1.29B AUM 80.18% 1-Year Est. Return
AAM
Anglepoint Asset Management George Town, Cayman Islands $1.28B AUM 131.9% 1-Year Est. Return
ALSV
ATP Life Science Ventures New York $898M AUM 84.86% 1-Year Est. Return

Waddell & Reed Financial's Q4 2017 Portfolio in Review

As of Q4 2017, Waddell & Reed Financial held 580 positions worth $45.1B, up 0.21% from $45B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Waddell & Reed Financial withdrew a net $2.51B in Q4 2017, closing 54 positions and reducing 261 holdings. Its most notable exit was Kite Pharma, Inc., an estimated $171M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Waddell & Reed Financial opened a new position in TE Connectivity worth $93.5M.

  • Waddell & Reed Financial's largest Q4 2017 buy was TE Connectivity: 983,623 shares worth $93.5M.
  • Waddell & Reed Financial added most to UnitedHealth in Q4 2017, an estimated $138M increase.
  • Waddell & Reed Financial's biggest Q4 2017 reduction was Philip Morris, cutting an estimated $219M.
  • Waddell & Reed Financial fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $171M.
  • Waddell & Reed Financial's ten largest holdings make up 19% of its $45.1B portfolio in Q4 2017.
  • Waddell & Reed Financial opened 61 new positions and closed 54 in Q4 2017.
  • Waddell & Reed Financial's portfolio value rose 0.21% quarter-over-quarter to $45.1B.

Based on Waddell & Reed Financial's 13F filing for Q4 2017, filed 14 Feb 2018.